Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane vs Taxol with Bevacizumab in Adjuvant Breast Cancer
NCT00394251Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Aug 2006
- Primary completion
- Mar 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Celgene Corporation. Started Aug 2006; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00394251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394251.